RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+33.41%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.57B
AUM Growth
+$452M
(+21%)
Cap. Flow
-$55.1M
Cap. Flow
% of AUM
-2.14%
Top 10 Holdings %
Top 10 Hldgs %
31.92%
Holding
139
New
6
Increased
46
Reduced
13
Closed
9
Top Buys
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
$20.7M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$16.9M |
| 4 |
Cigna
CI
|
$14.5M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$10.8M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$44.7M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$33.8M |
| 3 |
Molina Healthcare
MOH
|
$19.1M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$18.7M |
| 5 |
Biogen
BIIB
|
$15M |
Sector Composition
| 1 | Healthcare | 86.14% |
| 2 | Consumer Staples | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
26
DELISTED
Wright Medical Group Inc
WMGI
| $29M | 1.12% |
920,608
-79,392
| -8% | -$2.5M |
|
|
ONC
27
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $28.4M | 1.09% |
214,800
| – | – |
|
28
Acadia Healthcare
ACHC
$2.19B
| $27.1M | 1.05% |
925,000
+24,250
| +3% | +$711K |
|
|
NVTA
29
DELISTED
Invitae Corporation
NVTA
| $26.9M | 1.04% |
1,150,000
-250,000
| -18% | -$5.86M |
|
30
Idexx Laboratories
IDXX
$51.4B
| $26.9M | 1.04% |
120,200
+9,700
| +9% | +$2.17M |
|
31
Incyte
INCY
$16.9B
| $26.9M | 1.04% |
312,300
+2,300
| +0.7% | +$198K |
|
|
PRAH
32
DELISTED
PRA Health Sciences, Inc.
PRAH
| $26.5M | 1.02% |
240,000
+40,000
| +20% | +$4.41M |
|
33
Ascendis Pharma
ASND
$12.5B
| $25.1M | 0.97% |
213,500
-30,000
| -12% | -$3.53M |
|
34
Insmed
INSM
$30.7B
| $24.7M | 0.95% |
850,000
| – | – |
|
35
Baxter International
BAX
$12.5B
| $24.5M | 0.94% |
300,700
| – | – |
|
36
Collegium Pharmaceutical
COLL
$1.21B
| $23.9M | 0.92% |
1,577,893
-27,212
| -2% | -$412K |
|
|
RDUS
37
DELISTED
Radius Health, Inc.
RDUS
| $23.4M | 0.9% |
1,175,000
+75,000
| +7% | +$1.5M |
|
38
argenx
ARGX
$45.9B
| $22.7M | 0.87% |
181,700
+3,700
| +2% | +$462K |
|
39
Thermo Fisher Scientific
TMO
$186B
| $22.2M | 0.85% |
81,000
-15,000
| -16% | -$4.11M |
|
|
BPMC
40
DELISTED
Blueprint Medicines
BPMC
| $22M | 0.85% |
275,000
+61,342
| +29% | +$4.91M |
|
41
Alnylam Pharmaceuticals
ALNY
$59.2B
| $21.8M | 0.84% |
233,500
+39,500
| +20% | +$3.69M |
|
|
EPZM
42
DELISTED
Epizyme, Inc
EPZM
| $21.7M | 0.84% |
1,753,375
+145,875
| +9% | +$1.81M |
|
|
ALDR
43
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $21.3M | 0.82% |
1,560,000
+85,000
| +6% | +$1.16M |
|
|
CVET
44
DELISTED
Covetrus, Inc. Common Stock
CVET
| $20.7M | 0.8% |
+650,000
| New | +$20.7M |
|
|
BOLD
45
DELISTED
Audentes Therapeutics, Inc
BOLD
| $20.4M | 0.79% |
522,500
+22,500
| +5% | +$878K |
|
|
MDCO
46
DELISTED
Medicines Co
MDCO
| $20.4M | 0.79% |
729,400
+2,500
| +0.3% | +$69.9K |
|
47
Galapagos
GLPG
$2.2B
| $19.4M | 0.75% |
165,000
-12,500
| -7% | -$1.47M |
|
48
Travere Therapeutics
TVTX
$1.93B
| $18.8M | 0.72% |
830,000
+430,000
| +108% | +$9.73M |
|
|
RARX
49
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $18M | 0.69% |
804,000
+54,000
| +7% | +$1.21M |
|
50
Puma Biotechnology
PBYI
$253M
| $17.8M | 0.69% |
458,000
+1,538
| +0.3% | +$59.7K |
|